Carregant...

Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes

Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of insulin-producing cells. Due to the ability of apoptotic cells clearance to induce tolerance, we previously generated liposomes rich in phophatidylserine (PS) –a feature of apoptotic cells– loaded with insulin peptides to mi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Adrian Villalba, Silvia Rodriguez-Fernandez, Rosa-Maria Ampudia, Mary Cano-Sarabia, David Perna-Barrull, Cesc Bertran-Cobo, Clara Ehrenberg, Daniel Maspoch, Marta Vives-Pi
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis Group 2020-01-01
Col·lecció:Artificial Cells, Nanomedicine, and Biotechnology
Matèries:
Accés en línia:https://www.tandfonline.com/doi/10.1080/21691401.2019.1699812
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!